BBC Health 09 Sep 2026
Very hot drinks may damage the food pipe and increase cancer risk
A study found people who had their drinks "very hot" had around a three times higher risk of the cancer…
09 Sep 2026
Read →
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The purpose of this multicenter, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy of TUB-040 and…
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is…
This study aims to address the unmet medical need of participants with metastatic colorectal cancer (mCRC) who have previously been treated with…
Colorectal cancer is 37% higher in the North West than the national average and is treated by chemotherapy, including fluorouracil, capecitabine, and…
This is a multi-site, global, open-label study that includes a phase 1b evaluation of elacestrant in combination with abemaciclib in women and…
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after…
Your patient insight is valuable. Take a short survey and help researchers improve treatments for Cancer.
Living with Cancer? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Cancer. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Cancer patients.
TA1190
TA1189
TA1186
📋 Information sourced from clinical trial registries, FDA, EMA and published research
View all research →No podcasts available yet for Cancer
Sign up for updates below to be notified when we release a free patient podcast for this area.